ArticlePrzeglad menopauzalny = Menopause review2025
Adenosarcoma of the uterine cervix - a novel case report and review of the literature.
Article in Przeglad menopauzalny = Menopause review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenosarcomas constitute approximately 1% of all malignancies affecting the female reproductive system. Their most common locations are the uterine corpus and ovaries. Cervical adenosarcomas are rare and poorly described in the literature. Therefore, there are still no treatment guidelines for such cases, and the proper scope of the surgical procedure has become questionable. The most popular options include total abdominal hysterectomy and/or bilateral salpingo-oophorectomy (BSO). Generally, the prognosis is relatively good, among other things, because it is detected in the earlier International Federation of Gynaecology and Obstetrics stage than other locations, with a 5-year overall survival rate of 63-84%. Here, the present paper describes the case of a 44-year-old female with adenosarcoma located in the cervix. The patient experienced abnormal vaginal bleeding occurring 7-10 days before proper menstruation and pelvic pain. Interestingly, despite a normal routine Pap smear test, the cervical mass was revealed in transvaginal ultrasonography. A subsequent biopsy of the lesion confirmed the presence of low-grade adenosarcoma. A radical hysterectomy (RH) with BSO and pelvic lymph node sampling was performed. The patient reports resolution of all symptoms. Our case study highlights the effectiveness of RH as the mainstay treatment for cervical adenosarcomas. Furthermore, we discuss these tumours' pathology and imaging features, as well as other therapeutic options. The present study has an exceptional value for practicing gynaecologists and oncologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.